Teva Pharmaceutical Q2 2023 Earnings Results

Loading viewer...

earnings

Format: PDF earnings

Teva Pharmaceutical Industries presents second quarter 2023 financial results and operational performance, covering generic pharmaceuticals, innovative medicines including AUSTEDO and COPAXONE, and biosimilar portfolio development. The presentation addresses competitive positioning, pipeline strategies, and risk factors affecting the company's outlook in a dynamic pharmaceutical market.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Teva Pharmaceutical Industries Ltd.

View all →

Teva Pharmaceutical 2024 J.P. Morgan Healthcare Conference

conference

18 Pages

Teva Pharmaceutical Q1 2022 Results

earnings

Similar earningss from other companies

Browse all →

Kempower Financial Statements 2022 Q4 Results

earnings

24 Pages

Kempower

Banca Generali FY 2022 Results Investor Presentation 2023

earnings